Exhibit 23.3

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated March 4, 2024, with respect to the consolidated financial statements of Purple Biotech Ltd., incorporated herein by reference and to the reference to our firm under the heading Experts in the prospectus.

/s/ Somekh Chaikin                               

Somekh Chaikin

Member Firm of KPMG International

Tel Aviv, Israel

March 28, 2024